22
Views
8
CrossRef citations to date
0
Altmetric
Review

The retinoblastoma gene family: its role in cancer onset and progression

&
Pages 765-783 | Published online: 25 Feb 2005
 

Abstract

In the recent past, a considerable amount of scientific literature has revealed impressive mechanisms that exist to safeguard development and homeostasis in high eukaryotes, and has identified a complex molecular machinery regulating proliferation, differentiation and cell death in mammalian cells. Alteration in at least two of these regulatory circuits is essential for transforming normal cells into malignant ones. During the second half of this century, research focused on the identification and characterisation of genes directly involved in malignant transformation and emphasised that tumourigenesis in humans is the result of a multi-step process reflecting genetic alterations, progressively pushing normal cells towards highly malignant derivatives. Because several human tumours involve loss of heterozygosity of tumour suppressor genes, it is now well accepted that mutations of these genes play a key role in malignant transformation. Current approaches in molecular research have aimed at developing more efficient therapies based on restoring the lost function of genes directly involved in malignant transformation. Since the retinoblastoma (RB) gene family, pRb/p105, pRb2/p130 and p107, has been shown to suppress neoplastic growth, these tumour suppressor genes offer an attractive therapeutic target for treating disorders involving cell growth. This review examines the functional regions of RB family members and the involvement of these genes in controlling cell cycle, apoptosis, differentiation and angiogenesis, highlighting the findings of in vitro and in vivo studies, and focusing on the role of RB proteins in tumourigenesis and in the design of potential approaches for gene therapy development.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.